Cerebral Palsy Clinical Trial
— BeFASTOfficial title:
Linking Neuroplasticity With the Outcomes of Motor Learning Based Interventions: Multi-modal Evaluation of Walking-based Training in Children and Youth With Cerebral Palsy
NCT number | NCT02584491 |
Other study ID # | 14-519 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | July 2015 |
Est. completion date | December 2016 |
Verified date | January 2019 |
Source | Holland Bloorview Kids Rehabilitation Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The purpose of this study is to determine the associations between changes in neural activity and structure, advanced gross motor skills, gait characteristics, and physical activity participation following a gait-related intervention that is based on motor learning principles for ambulatory children and youth with hemiplegic and diplegic cerebral palsy. The investigators' hypothesis is that in conjunction with a program of motor learning based training, functional neuroplastic changes in the involved motor areas will be strongly associated with changes in gait and advanced gross motor skills, moderately associated with physical activity based participation changes, and will have a fair association with structural neuroplastic change.
Status | Completed |
Enrollment | 9 |
Est. completion date | December 2016 |
Est. primary completion date | December 2016 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 7 Years to 17 Years |
Eligibility |
Inclusion Criteria: - Age 7 to17 years inclusive; - GMFCS Level I or II; - Able to follow testing and motor imagery instructions; - Able to actively participate in a minimum of 45 minutes of physical activity; - Able to independently dorsiflex both ankles; - Able to commit to attendance of sessions two to three times weekly for six weeks. Exclusion Criteria: - Orthopaedic surgery within the last 9 months (muscle) or 12 months (bone); - Botulinum toxin-A (BTX-A) injections to lower limb in the last 4 months; - Inability to discontinue BTX-A for period of 12 weeks (during trial) due to concerns about ROM or pain; - Severe spasticity (may be a contraindication for neuroimaging procedures); - Seizure disorder (if not fully controlled by medication for the 12 months); - Not prepared or unable to discontinue a regular lower limb therapy intervention during the course of the trial; - Involved in another intervention study; - Standard MRI contraindications (e.g., metal implants such as cochlear implant, claustrophobia). |
Country | Name | City | State |
---|---|---|---|
Canada | Holland Bloorview Kids Rehabilitation Hospital | Toronto | Ontario |
Lead Sponsor | Collaborator |
---|---|
Holland Bloorview Kids Rehabilitation Hospital | The Hospital for Sick Children |
Canada,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Body Pain | Use of FACES pain scale and body diagrams to show areas of pain (musculoskeletal and other) | Completed 2 minutes before and 2 minutes after each intervention session | |
Other | Intervention enjoyment, assessed using a modified version of the Physical Activity Enjoyment Scale (PACES) | Participants' enjoyment of the intervention sessions will be assessed every 2 weeks, with the questionnaire administered by a research team member not involved in intervention delivery. | Week 2, 4, 6 | |
Other | Rating of exertion, assessed using Pictoral Children's Effort Rating Table (PCERT) | Children will be asked to complete PCERT at mid-point of each session, and 2 minutes before session completion | Completed at 22 minutes (mid-point) and at 43-minutes (2-minutes before end) of each intervention session | |
Other | Heart Rate | Heart rate will be monitored by treating kinesiologist. | Assessed at 4 time points per session: 1 min before start of session, at 22 minutes (mid-point), at 43-minutes (2-min before end), and at 45-minutes (end) of each session. | |
Primary | Change from baseline in functional activity in lower-limb related cortical areas, assessed using functional MRI (fMRI) | 7 days pre/7 days post training intervention | ||
Primary | Change from baseline in advanced motor skills on the Challenge Module | The Challenge Module is a new published measure of advanced motor skills. | 7 days pre/7 days post/4-months post training intervention | |
Secondary | Change from baseline in resting state activity, assessed using resting state fMRI | 7 days pre/7 days post training intervention | ||
Secondary | Change from baseline in microstructure of brain, assessed using diffusion tensor imaging (DTI) | 7 days pre/7 days post training intervention | ||
Secondary | Change from baseline in Physical Activity self-efficacy | Participant-report measure of Task efficacy and Barrier efficacy for physical activity. | 7 days pre/7days post/4-months post training intervention | |
Secondary | Change from baseline in walking activity, assessed using a StepWatch accelerometer | Participants will wear the StepWatch for 5 days. | 7 days pre/7days post/4-months post training intervention | |
Secondary | Change from baseline in gait kinematics as measured using an electronic walkway | Time/distance parameters of footsteps via GAITRite system. | 7 days pre/7days post/4-months post training intervention | |
Secondary | Change from baseline in gait kinetics/kinematics as measured using 3D motion capture system | Whole body gait analysis via Vicon motion capture and Bertec force plates. | 7 days pre/7days post/4-months post training intervention | |
Secondary | Change from baseline in physical activity participation, as measured using the Participation and Environment Measure for Children/Youth (PEM-CY) | Parent-report measure of participation in the home, school and community, as well as environmental factors within each setting. | 7 days pre/7days post/4-months post training intervention | |
Secondary | Change from baseline in walk speed on the Six-minute walk test | Standardized 6 minute walk test (with shoes, orthoses, walking devices as required) to determine distance covered (capability measure). Well-validated in pediatric CP. | 7 days pre/7days post/4-months post training intervention | |
Secondary | Change from baseline in targeted goal abilities and satisfaction with performance as measured by the Canadian Occupational Performance Measure | Three to five individualized walking-based activity/participation set at baseline with assessor and child/parent, and re-evaluated by child/parent at post-intervention assessments | 7 days pre/7days post/4-months post training intervention | |
Secondary | Change from baseline in targeted goal abilities as measured by Goal Attainment Scaling (GAS) | Three to five individualized walking-based activity/participation set at baseline with assessor and child/parent, and re-evaluated by child/parent at post-intervention assessments | 7 days pre/7days post/4-months post training intervention | |
Secondary | Motor learning content of interventions, as assessed using the Motor Learning Strategy Rating Instrument (MLSRI) | The MLSRI is used to assess the extent to which motor learning strategies are used within an intervention session | Week 2, 4, 6 | |
Secondary | Motor learning as evaluated using retention and transfer tests | Individualized skills will be identified to practice at every session (retention) and only at sessions 5/10/15 (transfer) to evaluate motor learning | Week 2, 4, 6 | |
Secondary | Change from baseline in lower-limb proprioception | Lower limb joint-sense position and kinesthesia will be assessed using a semi-goniometer (protocol modified from Wingert et al, 2009) | 7 days pre/7days post/4-months post intervention | |
Secondary | Mental chronometry: walking | Participants will be timed while walking a 10-meter distance, and then timed while imagining walking the same distance. | 7 days pre/7days post/4-months post intervention |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05317234 -
Genetic Predisposition in Cerebral Palsy
|
N/A | |
Recruiting |
NCT05576948 -
Natural History of Cerebral Palsy Prospective Study
|
||
Completed |
NCT04119063 -
Evaluating Wearable Robotic Assistance on Gait
|
Early Phase 1 | |
Completed |
NCT03264339 -
The Small Step Program - Early Intervention for Children With High Risk of Developing Cerebral Palsy
|
N/A | |
Completed |
NCT05551364 -
Usability and Effectiveness of the ATLAS2030 Exoskeleton in Children With Cerebral Palsy
|
N/A | |
Completed |
NCT03902886 -
Independent Walking Onset of Children With Cerebral Palsy
|
||
Recruiting |
NCT05571033 -
Operant Conditioning of the Soleus Stretch Reflex in Adults With Cerebral Palsy
|
N/A | |
Not yet recruiting |
NCT04081675 -
Compliance in Children With Cerebral Palsy Supplied With AFOs
|
||
Completed |
NCT02167022 -
Intense Physiotherapies to Improve Function in Young Children With Cerebral Palsy
|
N/A | |
Completed |
NCT04012125 -
The Effect of Flexible Thoracolumbar Brace on Scoliosis in Cerebral Palsy
|
N/A | |
Enrolling by invitation |
NCT05619211 -
Piloting Movement-to-Music With Arm-based Sprint-Intensity Interval Training Among Children With Physical Disabilities
|
Phase 1 | |
Completed |
NCT04489498 -
Comparison of Somatometric Characteristics Between Cerebral Palsy and Normal Children, Cross-sectional, Multi Center Study
|
||
Completed |
NCT03677193 -
Biofeedback-enhanced Interactive Computer-play for Youth With Cerebral Palsy
|
N/A | |
Recruiting |
NCT06450158 -
Robot-assisted Training in Children With CP
|
N/A | |
Completed |
NCT04093180 -
Intensive Neurorehabilitation for Cerebral Palsy
|
N/A | |
Completed |
NCT02909127 -
The Pediatric Eating Assessment Tool
|
||
Not yet recruiting |
NCT06377982 -
Human Umbilical Cord Blood Infusion in Patients With Cerebral Palsy
|
Phase 1 | |
Not yet recruiting |
NCT06007885 -
Examining Capacity Building of Youth With Physical Disabilities to Pursue Participation Following the PREP Intervention.
|
N/A | |
Not yet recruiting |
NCT03183427 -
Corpus Callosum Size in Patients With Pineal Cyst
|
N/A | |
Active, not recruiting |
NCT03078621 -
Bone Marrow-Derived Stem Cell Transplantation for the Treatment of Cerebral Palsy
|
Phase 1/Phase 2 |